🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Genetic Basis of SARS-CoV-2 Infection-Associated Multisystem Inflammatory Syndrome in Children (MIS-C)

Recruitingn/aAges 2 Years - 65 YearsAllIstituto Giannina Gaslini
NCT07881068 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The project aims to investigate the molecular basis of pediatric inflammatory conditions associated with COVID-19 identified by the IDEA network, with the objectives of characterizing their genetic background, pathophysiology, and clinical spectrum, improving therapeutic strategies, defining follow-up programs, and identifying individuals at risk.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients presenting with specific clinical features characteristic of MIS-C and Kawasaki disease. Exclusion Criteria: * Patients presenting with other diseases.
💊

What it tests

  • Not listed
📍

Where

3 sites
ASST Papa Giovanni XXIII
Bergamo, Italy
IRCCS Ospedale San Raffaele
Milan, Italy
IRCCS Materno-Infantile Burlo Garofolo
Trieste, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy